<HashMap><database>EGA</database><scores/><additional><omics_type>Genomics</omics_type><dataset_type>N/A</dataset_type><full_dataset_link>https://ega-archive.org/datasets/EGAD00001003910</full_dataset_link><sample_count>11138</sample_count><description>EGA dataset EGAD00001003910</description><repository>EGA</repository><title>Single-cell RNA sequencing on 11,138 single T cells from 12 colon and rectal cancer (CRC) patients</title><description_synonyms>RNA Sequence Determination, Activity, Laboratory, Sequence Determination, Blood, RNA Sequence, T-Lymphocyte, F20O9_210, Social Controls, dmTAF[[II]]230, T Lymphocyte, Analysis, Research Activity, HPA, immature T cell, Laboratory Research, Formal Social Controls, Atf4, maternal, 929, Priorities, average, treatment, DmelCG8669, TFIID TAF250, Analyses, cel, Determination, T-Cells, Tissue, F20O9.210, non-PKU mild, bu, T, "PKU" EXACT [MTHICD9_2006:270.1], CRUCIFERIN C, Sequence Determinations, large intestine cancer, Social, T Cells, disease management, Therapies, PAH, Pah, Research Priority, Thymus Dependent Lymphocytes, somatic mutation, colorectal (colon or rectal) cancer, Therapy, dTAF[[II]]230, anatomical protrusion, potp, TAF200, "PKU" EXACT [MTH:NOCODE], Research Priorities, pah, TAFII-250, TAF250/230, Determinations, Manchuria, Phenylketonuria, TAFII250, DTPH, T-Cell, simple tissue, l(2)crc, anon-EST:fe3D7, "PKU" EXACT [CSP2005:1849-1234], Research and Development, T-cell, cruciferin 3, Mainland China, susceptibility to, Thymus-Dependent, Control, phenylpyruvic oligophrenia, T-lymphocyte, Controls, CG17603, TAF[[II]], Treatments, cancer of large bowel, Thymus-Dependent Lymphocyte, Activities, ATF-4, T cell, Taf250, Patient, spine, SR3-5, PBMCs, Cells, cancer of the large bowel, CG8669, T Cell, cancer of large intestine, mKIAA0147, ATF4/crc, other neoplasm, Regulation, TAF230, AI118201, Regulations, Policies, d230, Thymus-Dependent Lymphocytes, Clr, oligophrenia Phenylpyruvica, dTAFII250, EfW1, autosomal dominant, phenylketonuria, protrusion, colorectal cancer, dATF-4, dmTAF1, Taf230, PBMC, anon-EST:Liang-2.17, anon-EST:Liang-2.11, clone 2.11, CG7399, TAF250, Taf200, dTAF[[II]]250, Research, cell, clone 2.17, TPH, Tph, Scrb1, CG9429, Taf1p, Ire1, Sequencing, cancer of the large intestine, dTAF250, RNA Sequence Analyses, vartul, Clients, mature T cell, "phenylalaninemia" EXACT [CSP2005:1849-1177], RNA Sequencing, Development and Research, TAF, T Lymphocytes, Lymphocyte, "Phenylketonuria" EXACT [SNOMEDCT_2005_07_31:190687004], Sequence Analyses, RNA, data, DmelCG7399, TAF[[II]]250, Non-phenylketonuria hyperphenylalaninemia, whole blood, TRH, Trh, Formal Social Control, RNA Sequence Determinations, imbecilitus phenylpyruvica, SCRIB1, PKU1, l(3)84Ab, BG:DS00004.13, eth, Client, People's Republic of China, Cell, dTAF230, Inner Mongolia, Priority, Social Control, p230, Sinkiang., Research Activities, "Phenylketonuria [PKU]" EXACT [ICD9CM_2006:270.1], TAF[[II]]250/230, TFIID, Crc, CRC, T lymphocyte, PKU, Taf[[II]]250, large bowel cancer, TAF[[II]]230, Peripheral Blood, crc, Lymphocytes, TAF[II]250, CRIB, oligophrenia phenylpyruvica, Reticuloendothelial System, DmelCG9429, crt, DmelCG17603, colon cancer, Therapeutic, RNA Sequence Analysis, "Phenylketonuria" EXACT [SNOMEDCT_2005_07_31:154735006], Treatment, regulation, PH, TAF1</description_synonyms><name_synonyms>Vasp, VASP, DmelCG15112, ENHANCER OF ATNSI ACTIVITY, Data Set, MENA, NDPP1, l(2)02029, Enb, enb, ENA, Ena, CG15112, 2018., ENA/VASP</name_synonyms></additional><is_claimable>false</is_claimable><name>ena-DATASET-BIOPIC-18-01-2018-07:47:13:659-496 - samples</name><description>Deep single-cell RNA sequencing data for 11,138 T cells from tumour, adjacent normal tissue and peripheral blood of treatment-naive CRC patients. The DATA ACCESS AGREEMENT is provided at https://github.com/zhangyybio/single-T-cell-data-access. Applicants can request access to the data by directly downloading it or by sending an email to cancerpku@pku.edu.cn. The process that is used to approve an application includes verifying the institution, participants and research purposes of the application. In general this process will take about two weeks. In principal, any academic research institutions complying with the laws and bioethic regulation policies of China will be approved.</description><dates><updated>2019-06-23 17:22:45</updated></dates><accession>EGAD00001003910</accession><cross_references><TAXONOMY>9606</TAXONOMY><EGA>EGAC00001000551</EGA><EGA>EGAS00001002791</EGA></cross_references></HashMap>